NO905090D0 - INTERLEUKIN-1 INHIBITORS. - Google Patents

INTERLEUKIN-1 INHIBITORS.

Info

Publication number
NO905090D0
NO905090D0 NO905090A NO905090A NO905090D0 NO 905090 D0 NO905090 D0 NO 905090D0 NO 905090 A NO905090 A NO 905090A NO 905090 A NO905090 A NO 905090A NO 905090 D0 NO905090 D0 NO 905090D0
Authority
NO
Norway
Prior art keywords
interleukin
inhibitors
Prior art date
Application number
NO905090A
Other languages
Norwegian (no)
Other versions
NO905090L (en
NO316122B1 (en
Inventor
Charles H Hannon
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of NO905090D0 publication Critical patent/NO905090D0/en
Publication of NO905090L publication Critical patent/NO905090L/en
Publication of NO316122B1 publication Critical patent/NO316122B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO19905090A 1988-05-27 1990-11-23 DNA sequence encoding interleukin-1 inhibitors, recombinant vector containing and capable of encoding the DNA sequence, host cell containing and can express vectors, and method for producing interleukin-1 inhibitors, and recombinant host cell s. NO316122B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (3)

Publication Number Publication Date
NO905090D0 true NO905090D0 (en) 1990-11-23
NO905090L NO905090L (en) 1991-01-28
NO316122B1 NO316122B1 (en) 2003-12-15

Family

ID=27394086

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19905090A NO316122B1 (en) 1988-05-27 1990-11-23 DNA sequence encoding interleukin-1 inhibitors, recombinant vector containing and capable of encoding the DNA sequence, host cell containing and can express vectors, and method for producing interleukin-1 inhibitors, and recombinant host cell s.
NO20014783A NO316917B1 (en) 1988-05-27 2001-10-01 Process for the preparation of a pharmaceutical composition containing an interleukin-1 inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20014783A NO316917B1 (en) 1988-05-27 2001-10-01 Process for the preparation of a pharmaceutical composition containing an interleukin-1 inhibitor

Country Status (9)

Country Link
JP (2) JP3192651B2 (en)
KR (1) KR970002917B1 (en)
BR (1) BR8907457A (en)
DK (1) DK172763B1 (en)
FI (2) FI109206B (en)
HU (3) HU9803037D0 (en)
NO (2) NO316122B1 (en)
OA (1) OA09631A (en)
WO (1) WO1989011540A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
DE69131044T2 (en) * 1990-05-01 1999-11-18 Chiron Corp INTERLEUKIN-I ANTAGONIST AND ITS USE
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5840496A (en) * 1990-10-09 1998-11-24 Chiron Corporation Method for diagnosing endometrial cancer
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
EP1442132A2 (en) * 2001-10-26 2004-08-04 Novartis AG Methods for the treatment of osteoarthritis and compositions thereof
MXPA04009681A (en) 2002-04-05 2005-01-11 Amgen Inc Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors.
US7709611B2 (en) 2004-08-04 2010-05-04 Amgen Inc. Antibodies to Dkk-1
NO2188313T3 (en) 2007-08-21 2018-03-31
JP5976319B2 (en) * 2008-09-12 2016-08-23 エックスバイオテク，インコーポレイテッドＸｂｉｏｔｅｃｈ，Ｉｎｃ． Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
ES2600616T3 (en) 2011-03-14 2017-02-10 Phlogo Aps Interleukin-1 receptor antagonists
AU2012242666A1 (en) 2011-04-15 2013-11-28 Merck Patent Gmbh Anti- IL-1R1 inhibitors for use in cancer
TW201605896A (en) 2013-08-30 2016-02-16 安美基股份有限公司 GITR antigen binding proteins
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
TWI742054B (en) 2016-03-08 2021-10-11 美商健生生物科技公司 Gitr antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855747T2 (en) * 1987-08-26 1997-06-12 Biogen Inc BIOLOGICAL MATERIALS, THEIR PRODUCTION AND USE IN THERAPY

Also Published As

Publication number Publication date
FI20020545A (en) 2002-03-21
BR8907457A (en) 1991-04-02
NO316917B1 (en) 2004-06-21
DK172763B1 (en) 1999-07-05
DK8591D0 (en) 1991-01-18
HU215434B (en) 1999-04-28
NO905090L (en) 1991-01-28
WO1989011540A1 (en) 1989-11-30
AU633831B2 (en) 1993-02-11
NO316122B1 (en) 2003-12-15
HU222810B1 (en) 2003-11-28
JP2001029093A (en) 2001-02-06
JPH03505279A (en) 1991-11-21
DK8591A (en) 1991-01-18
HU893412D0 (en) 1991-05-28
FI109206B (en) 2002-06-14
NO20014783D0 (en) 2001-10-01
HU9803037D0 (en) 1999-11-29
AU3746989A (en) 1989-12-12
KR970002917B1 (en) 1997-03-12
OA09631A (en) 1993-04-30
NO20014783L (en) 1991-01-28
JP3192651B2 (en) 2001-07-30
FI905812A0 (en) 1990-11-26

Similar Documents

Publication Publication Date Title
FI895343A0 (en) PAO MULTIVAOGLAENGD ARBETANDE MEDICINSKT LASERSYSTEM.
ATE97652T1 (en) PEPTIDA INHIBITORS.
DE68924670D1 (en) Alpha-glucosidase inhibitors.
DE68904083T2 (en) HMG-COA REDUCTINE INHIBITORS.
NO905090D0 (en) INTERLEUKIN-1 INHIBITORS.
DE68901091D1 (en) HMG-COA REDUCTINE INHIBITORS.
FI880218A (en) OEPPNINGS- OCH STAENGNINGSANORDNING FOER TAKLUCKA I FORDON.
FI882194A0 (en) MELLANLAGRINGSSYSTEM FOER GLASSKIVPAR I EN VINDRUTEPRODUKTIONSLINJE.
FI881581A0 (en) STYRSYSTEM I HYDRAULISKT MANOEVERORGAN.
DK69489D0 (en) ASPARTATTRANSCARBAMYLASE INHIBITORS
NO884559L (en) TAUEOEYE FOR SLEPEWIRE.
FI885475A0 (en) PAO VAEGG GLIDANDE FOERVARINGSSYSTEM FOER CYKLAR.
FI880401A0 (en) ANORDING FOR HUSVAGNAR.
FI883520A (en) ANORDNING PAO SKIDA.
FI885658A0 (en) PAO TELEFONSYSTEM BASERAT KONTROLLFOERFARANDE.
FI884365A0 (en) IMPORTANT IMPORTANCE.
FI883099A0 (en) BRAENNANORDNING FOER FAST BRAENSLE.
FI885740A (en) STOEDHJULSYSTEM FOER SCHAKTNINGSMASKINS BREDA LARVBAND.
FI883506A (en) STABILIZERINGANORDNING FOER DRAGARMARNA I EN TRAKTOR.
FI883715A (en) I BOGGIEHJUL GRIPANDE FOERFLYTTNINGSANORDNING.
FI881555A0 (en) BEHANDLINGSANORDNING FOER HUSHAOLLSVATTEN FOER TRYCKVATTENANLAEGGNINGAR I SMAOFASTIGHET.
FI882428A0 (en) ANORDING I RULLPACKMASKIN.
FI882209A0 (en) KARMPROFIL FOER EN FOENSTERKARM I EN VAEGGKONSTRUKTION.
FI880648A0 (en) STOMBLAD I LASTBIL.
FI880427A0 (en) PRESSVALS I PAPPERSMASKIN.

Legal Events

Date Code Title Description
LC4 Limitation of patent rights - b3 (par. 39b patent act)
MK1K Patent expired